The Truth About Generic Drugs

凯瑟琳·埃班 / 高天羽民主与建设出版社 · ChinaApr 2026

Rating 4.4
Word count
229K words
Chapters
43
ISBN
9787513931229

Tags

Documentary Literature Global Supply ChainPublic HealthPharmaceutical IndustryCommercial EthicsRegulatory LoopholesDrug SafetyTruth SeekingIn-Depth InvestigationDocumentary NarrativeInvestigative Writing

Summary

Are generic drugs really cheaper alternatives with equal efficacy? A decade-long in-depth investigation reveals the shocking truth behind the global generic drug supply chain! A Stanford Business School reading list pick and a New York Times "100 Notable Books of 2019"! Douban rating 9.0! Recommended by Peking University professor Wang Yifang and Pulitzer Prize winner James Risen! Acclaimed translator Gao Tianyu brings this cinematic work of literary reportage to readers in a crisp, highly readable narrative. Through the distinctive lens of narrative journalism, a complex reality is made clear and accessible; by following individuals across production, sales, and regulation, the book gradually lifts the veil on every link of the global supply chain. Generic drugs are legal, low-cost versions produced after brand-name patents expire. They are said to have nearly the same composition and effect as brand-name drugs. Their widespread use has been hailed as "the greatest public health advance of the 21st century." Today, generics account for nearly 90 percent of the pharmaceutical market. But what is the industry really like? Is it full of unscrupulous counterfeiters, or does it include discounters committed to quality? Katherine Eban's decade-long investigation of the global generic drug supply chain exposes hidden safety hazards and the alarming risks they pose to public health worldwide.

Editor's review

The Truth About Generic Drugs is a work of reportage that shook the global pharmaceutical industry. Through a decade-long investigation, Katherine Eban uncovers the untold secrets behind the generic drug business. The book does not simply condemn generics—they are an important means of lowering medical costs and broadening access—but targets an industry scandal: some companies sacrificing quality oversight in pursuit of profit. Using Indian pharmaceutical giant Ranbaxy as her entry point, Eban draws on internal documents, interviews with witnesses, and on-the-ground reporting to detail data fraud, cut corners in manufacturing standards, and regulatory loopholes with striking clarity. These practices not only endanger patients but also erode trust in health systems worldwide. As an editor, I believe the book's value goes far beyond ordinary popular science; it blends the sharpness of investigative journalism with professional concern for public health and the complex narrative of a global supply chain. Reading it, you feel an urgent sense of reality: the small pill in the bottle carries the weight of ethics, regulation, and life. Eban's writing is calm and restrained yet immensely powerful, prompting us to reconsider the true cost of cheapness.

Who it's for

A good fit for

Not a good fit for

Reading tips

  1. Read alongside recent news on pharmaceutical regulation to appreciate how the book's issues persist
  2. Slow your pace where necessary; the book contains many technical details and investigative threads
  3. After reading, reflect on your own right to be informed and your responsibility in medical choices

About the publisher

民主与建设出版社 China · Founded in 1994

Founded in 1994, Democracy and Construction Press organizes its publishing around economic management, the humanities and history, and united front culture, while also covering foreign literature and classic works. Among the 732 titles in the collection are translations of foreign classics such as The Brothers Karamazov and On War, fantasy literature such as The Lord of the Rings Trilogy: Illustrated Collector's Edition, and modern literary masterpieces including Lao She's Four Generations Under One Roof and Camel Xiangzi · The Problem of Nothing, and Lu Xun's Call to Arms. Translators Geng Jizhi and Wang Jinhua, together with authors such as J. R. R. Tolkien and Carl von Clausewitz, form the resource base for its combination of scholarly translation and general reading. As public information is limited, this description focuses on the publishing profile reflected in the titles held in the collection.

Contents

  1. 版权信息
  2. 前言
  3. 关于这次报道
  4. 重要人物及地点
  5. 序
  6. 第一部 形势转变
  7. 第一章 眼光长远的男人
  8. 第二章 药海淘金
  9. 第三章 富人的贫民窟
  10. 第四章 品质的语言
  11. 第五章 警灯亮起
  12. 第二部 印度崛起
  13. 第六章 自由战士
  14. 第七章 每天一美元
  15. 第八章 用聪明的方法做事
  16. 第九章 萨库尔的任务
  17. 第三部 猫鼠游戏
  18. 第十章 对全世界隐瞒
  19. 第十一章 世界地图
  20. 第十二章 制药界的法老
  21. 第四部 立案调查
  22. 第十三章 从阴影中现身
  23. 第十四章 “不要交给美国药监局”
  24. 第十五章 “问题有多严重？”
  25. 第十六章 钻石和红宝石
  26. 第十七章 “你怎么就不明白”
  27. 第五部 黑暗中的侦探
  28. 第十八章 国会觉醒了
  29. 第十九章 寻找未知变量
  30. 第二十章 一次考验耐力的检测
  31. 第二十一章 一口黑暗的深井
  32. 第二十二章 价值6亿美元的封套
  33. 第六部 分水岭
  34. 第二十三章 电灯开关
  35. 第二十四章 我们是冠军
  36. 第二十五章 崩溃的文件
  37. 第二十六章 终极检测实验室
  38. 第七部 清算
  39. 第二十七章 苍蝇太多，数不过来
  40. 第二十八章 立场问题
  41. 尾声
  42. 致谢
  43. 术语表

FAQ

Does the book completely condemn generic drugs? No. The author explicitly affirms the important social value of generics; her criticism targets fraud and violations by some companies seeking profit, as well as the failure of regulatory systems.
Are the cases in the book representative? The author analyzes representative cases in depth, but the problems she reveals may be systemic risks across the global generic drug industry. The book also cites exemplary compliant companies for contrast.
Do I need a medical or pharmaceutical background to read it? No. The author explains key concepts in plain language, focusing on investigative narrative and logical analysis; general readers can fully grasp the core issues.

This site is an index: you start “Search all sources” in your browser, and the entries it lists all point to third-party sites; please judge their availability yourself.

About the author

凯瑟琳·埃班 Author

Katherine Eban is an author about whom limited public information is available; her nationality, dates of birth and death, and other biographical details are not reliably recorded in public sources. The library currently holds one work by her, the nonfiction book The Truth About Generic Drugs. This work indicates that her writing focuses on the pharmaceutical industry and public health issues, and that she tends to present facts through investigative reporting, translating complex industrial and regulatory matters into a narrative accessible to general readers. Such nonfiction writing usually relies on interviews with people involved, practitioners, and relevant institutions, as well as on the study of public documents and industry materials, and therefore tends to combine informational density with readability. Although details of her life remain unclear, The Truth About Generic Drugs has linked her name to topics such as drug quality and regulatory gaps. For readers who wish to understand how the pharmaceutical industry operates and how global health governance works, this book offers a noteworthy perspective.

高天羽 Author

Gao Tianyu is a Chinese translator and author whose work spans several fields. Public information about him is limited, and little is recorded about his life. Judging from the seventeen titles in the library, his translations and writings range across narrative nonfiction, popular science, medicine, science fiction, and world history. His representative translations include the cardiac surgeon's memoir Open Heart, the investigative report The Truth About Generic Drugs, The Thief Who Stole the Mind on Alzheimer's disease, and Neuro Logic, which explores human behavior and the workings of the brain; he has also translated A Knife's Edge Life, Catastrophe, and The Distant Earth Song. In his choice of material he favors works that combine professional depth with readable storytelling, and he is skilled at rendering specialized subjects such as medicine, neuroscience, and public health into fluent Chinese, helping readers understand science through narrative. His translations have thus gained a following among readers of popular science and narrative nonfiction.